Peter Lanyon

8.2k citations

87 papers · 3.4k indexed · 2 hit papers · h-index 29

Impact in

Rheumatology top 0.2%
- Systemic Lupus Erythematosus Research
- Osteoarthritis Treatment and Mechanisms
Nephrology top 2%
- Renal Diseases and Glomerulopathies

Papers in

Rheumatology 46
- Systemic Lupus Erythematosus Research 24
- Otitis Media and Relapsing Polychondritis 11
- Osteoarthritis Treatment and Mechanisms 6
Pathology and Forensic Medicine 21
- Systemic Sclerosis and Related Diseases 16

Co-authors: Michael Doherty Matthew J. Grainge Weiya Zhang Frances Rees Graham Davenport Rachel Jones David Jayne Fiona Pearce
Journals: Lara D. Veeken (36 papers)Annals of the Rheumatic Diseases (12 papers)Clinical Rheumatology (4 papers)Arthritis Care & Research (3 papers)The Lancet Rheumatology (3 papers)
Partner nations: United Kingdom United States Italy

In The Last Decade

Peter Lanyon

77 papers receiving 3.3k citations

Hit Papers

align trajectories log scale

The worldwide incidence and prevalence of systemic lupus erythematosus: a systematic review of epidemiological studies 2017 · 489 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2017 Lara D. Veeken
2008 Annals of the Rheumatic Diseases

Peers

Countries citing papers authored by Peter Lanyon

Since Specialization

Citations

This map shows the geographic impact of Peter Lanyon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Lanyon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Lanyon more than expected).

Fields of papers citing papers by Peter Lanyon

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter Lanyon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Lanyon. The network helps show where Peter Lanyon may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Peter Lanyon, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Peter Lanyon Line = papers co-authored together Peter Lanyon links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Trends in mortality due to haemophagocytic lymphohistiocytosis across 29 European countries from 2011 to 2021: a retrospective, international, population-based study The Lancet Rheumatology ·A. L. M. Muneer, Rodrigo Cantarero, 柳殿勤, Julián Flores Figueroa, Taghreed S. Farag, Mark Bishton, Matthew Collin, Richard Hubbard, Peter Lanyon, Rachel Tattersall, Jessica Manson, Fiona Pearce	2025	0
2	Patients’ experiences of managing their rare rheumatic disease Lara D. Veeken ·Emma Dures, Celia Almeida, Sadia Janjua, Andrew J. Hunt, Breogán Rioboó-Lois, Peter Lanyon, Nicola Walsh, Joanna Robson	2025	0
3	Impact of SARS-CoV-2 spike antibody positivity on infection and hospitalisation rates in immunosuppressed populations during the omicron period: the MELODY study The Lancet ·Lisa Mumford, Rachel Hogg, Julián Flores Figueroa, Peter Lanyon, Mary Bythell, Sean McPhail, Joseph Chilcot, Gillian Powter, Graham Cooke, Helen Ward, Helen Thomas, Stephen P. McAdoo, Liz Lightstone, Sean H. Lim, Gavin J. Pettigrew, Fiona Pearce, Michelle Willicombe	2025	1
4	OA42 Patient experiences of managing their rare rheumatic disease Lara D. Veeken ·Emma Dures, Celia Almeida, Andrew J. Hunt, Peter Lanyon, Nicola Walsh, Joanna Robson	2023	1
5	The BILAG-2004 index is associated with development of new damage in SLE Lara D. Veeken ·Chee‐Seng Yee, Caroline Gordon, Mohammed Akil, Peter Lanyon, Christopher Edwards, David Isenberg, Anisur Rahman, Lee‐Suan Teh, Sofia Tosounidou, Robert S. Stevens, Athiveeraramapandian Prabu, Bridget Griffiths, Neil McHugh, Ian N Bruce, Yasmeen Ahmad, Munther A. Khamashta, Vernon T. Farewell	2022	2
6	A validation study of the identification of haemophagocytic lymphohistiocytosis in England using population‐based health data British Journal of Haematology ·Mark Bishton, P Verdón, Tim Card, Peter Lanyon, Lu Ban, Lucy Elliss‐Brookes, Jessica Manson, Vasanta Nanduri, George Moussa, Luke Flower, María Dolores Mínguez Sánchez, Judith Rankin, Ethan S Sen, Rachel Tattersall, Colin Crooks, Takeda Tomosiro, T S S T Prabhat, Joe West, Mary Bythell	2021	3
7	A systematic review and meta-analysis of the incidence rate of Takayasu arteritis Lara D. Veeken ·Megan Rutter, 湊秀幸, Peter Lanyon, Matthew J. Grainge, Fiona Pearce	2021	37
8	COVID-19 infection, admission and death among people with rare autoimmune rheumatic disease in England: results from the RECORDER project Lara D. Veeken ·Megan Rutter, Peter Lanyon, Matthew J. Grainge, Richard Hubbard, Emily Peach, Mary Bythell, P Verdón, Takeda Tomosiro, Sarah Stevens, Fiona Pearce	2021	12
9	CLOK (University of Central Lancashire) ·Kathleen McElhone, Janice Abbott, M. A. Hurley, 順一川野瀬, Peter Lanyon, Anisur Rahman, Chee‐Seng Yee, Mohammed Akil, Ian N Bruce, Yasmeen Ahmad, Caroline Gordon, Lee‐Suan Teh	2020	6
10	Increased fasting small‐bowel water content in untreated coeliac disease and scleroderma as assessed by magnetic resonance imaging United European Gastroenterology Journal ·Ching Lam, David S. Sanders, Peter Lanyon, Klara Garsed, Stephen Foley, Susan E. Pritchard, Luca Marciani, Caroline L. Hoad, Carolyn Costigan, Penny Gowland, Robert E. Spiller	2019	5
11	The incidence, prevalence, and survival of systemic sclerosis in the UK Clinical Practice Research Datalink Clinical Rheumatology ·Jeremy Royle, Peter Lanyon, Matthew J. Grainge, Abhishek Abhishek, Fiona Pearce	2018	58
12	WS2_1 The UK & Ireland Vasculitis Registry (UKIVAS): Cross-sectional data on the first 2290 Patients with anti-neutrophil cytoplasm (ANCA) associated vasculitis (AAV) Lara D. Veeken ·Raashid Luqmani, Anthea Craven, J Sznajd, Neil Basu, Dragoș Hălmagi, David Jayne, Peter Lanyon, Mark A. Little, 李昱旻, Alan D. Salama, Richard A. Watts	2017	2
13	Can granulomatosis with polyangiitis be diagnosed earlier in primary care? A case–control study QJM ·Fiona Pearce, Richard Hubbard, Matthew J. Grainge, Richard A. Watts, Abhishek Abhishek, Peter Lanyon	2017	11
14	The worldwide incidence and prevalence of systemic lupus erythematosus: a systematic review of epidemiological studies Lara D. Veeken ·Frances Rees, Michael Doherty, Matthew J. Grainge, Peter Lanyon, Weiya Zhang Hit paper breakdown →	2017	489
15	Response to Rituximab in Patients with Refractory Systemic Lupus Erythematosus (SLE): Results from a National Multicentre Register UCL Discovery (University College London) ·(unknown), (unknown), David Isenberg, Anisur Rahman, David Jayne, Cathy Gordon, Wang Guan-qion, (unknown), (unknown), (unknown), Peter Lanyon, Benjamin Rhodes, B Griffiths, Edward M Vital, C-S Yee, (unknown), Mohamed Akil, الهه مکاریان پور, (unknown), Alexander Martyniuk, N. McHugh, مصطفى محمود درادكه, (unknown), MW Beresford, Ian N Bruce	2014	1
16	Is the Disease-Specific Lupusqol Sensitive To Changes of Disease Activity In Systemic Lupus Erythematosus Patients After Treatment of A Flare? Value in Health ·Kathleen McElhone, 順一川野瀬, Chris Sutton, Janice Abbott, Peter Lanyon, Anisur Rahman, Chee‐Seng Yee, Mohamed Akil, Yasmeen Ahmad, Ian N Bruce, Caroline Gordon, Lee Suan Teh	2014	1
17	The incidence and prevalence of systemic lupus erythematosus in the UK, 1999–2012 Annals of the Rheumatic Diseases ·Frances Rees, Michael Doherty, Matthew J. Grainge, Graham Davenport, Peter Lanyon, Weiya Zhang	2014	212
18	Distribution of radiographic osteoarthritis between the right and left hands, hips, and knees Arthritis & Rheumatism ·R Neame, Weiya Zhang, Chris Deighton, Michael Doherty, Sally Doherty, Peter Lanyon, Gary Wright	2004	51
19	Influence of radiographic phenotype on risk of hip osteoarthritis within families Annals of the Rheumatic Diseases ·Peter Lanyon, (unknown), (unknown), (unknown)	2004	15
20	Age and sex differences in hip joint space among asymptomatic subjects without structural change: Implications for epidemiologic studies Arthritis & Rheumatism ·Peter Lanyon, Kenneth Muir, Sally Doherty, Michael Doherty	2003	73

About Peter Lanyon

Peter Lanyon is a scholar working on Rheumatology, Pathology and Forensic Medicine, Immunology, Nephrology and Pulmonary and Respiratory Medicine, having authored 87 papers that have together received 3.4k indexed citations. Recurring topics across this work include Systemic Lupus Erythematosus Research (24 papers), Vasculitis and related conditions (23 papers), Systemic Sclerosis and Related Diseases (16 papers), Atherosclerosis and Cardiovascular Diseases (13 papers), Otitis Media and Relapsing Polychondritis (11 papers), Autoimmune and Inflammatory Disorders Research (7 papers), Immunodeficiency and Autoimmune Disorders (7 papers) and Osteoarthritis Treatment and Mechanisms (6 papers). The work is most often cited by research in Rheumatology (1.8k citations), Nephrology (311 citations), Immunology (841 citations), Genetics (404 citations) and Pulmonary and Respiratory Medicine (1.2k citations). Peter Lanyon has collaborated with scholars based in United Kingdom, United States and Italy. Frequent co-authors include Michael Doherty, Matthew J. Grainge, Weiya Zhang, Frances Rees, Graham Davenport, Rachel Jones, David Jayne, Fiona Pearce, Chetan Mukhtyar and Bhaskar Dasgupta. Their work appears in journals such as Lara D. Veeken, Annals of the Rheumatic Diseases, Clinical Rheumatology, Arthritis Care & Research and The Lancet Rheumatology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact